I'm a Pathologist. Do Sleep Peptides Work? DSIP, Epitalon, and Orexin

Why you wake up exhausted, why sleep and hunger run on the same brain circuit, and what sleep peptides like DSIP and Epitalon actually do. I'm a triple board-certified physician and pathologist, and I went through the published evidence to separate what's proven from what's mostly marketting. In 2000, researchers found that people with narcolepsy had lost 85 to 95 percent of one tiny population of brain cells. Those cells made a peptide called orexin, and it's what holds you awake right now. The same cells respond to whether you've eaten. On August 5, 2026, the FDA approved a drug built on that discovery. Weeks earlier, a peptide literally named sleep-inducing peptide went before an FDA advisory committee and was turned down. Almost nobody covered it. If you want the version of this I walk people through alongside metabolic health: https://getuninflamed.com CHAPTERS 00:00 The missing brain cells that keep you awake 01:02 Why you feel tired: sleep's brake and accelerator 03:31 Narcolepsy and the discovery of orexin 07:37 Signs of narcolepsy and cataplexy worth knowing 08:19 Do sleep drugs work? Blocking orexin for insomnia 10:11 The new narcolepsy drug: activating orexin 12:29 The evidence ladder for sleep treatments 13:47 DSIP: delta sleep-inducing peptide explained 15:03 Why the DSIP evidence fell apart 17:32 Epitalon, Semax, Selank, and the FDA vote 19:08 What's actually in the vial: the manufacturing ladder 20:13 What better peptide research would require 21:39 What actually works for sleep: CBT-I and more 24:48 Peptide hype, my own experience, and safety 25:32 What we know about sleep peptides REFERENCES 1. de Lecea L, et al. The hypocretins. PNAS. 1998. https://doi.org/10.1073/pnas.95.1.322 2. Sakurai T, et al. Orexins and orexin receptors. Cell. 1998. https://doi.org/10.1016/s0092-8674(00... 3. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000. https://doi.org/10.1016/S0140-6736(99... 4. Thannickal TC, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000. https://doi.org/10.1016/s0896-6273(00... 5. Tasali E, et al. Effect of sleep extension on energy intake in adults with overweight. JAMA Intern Med. 2022. https://doi.org/10.1001/jamainternmed... 6. Stefanou A, et al. Dual orexin receptor antagonists and sleep: meta-analysis. Sleep Med. 2026. https://doi.org/10.1016/j.sleep.2026.... 7. Dauvilliers Y, et al. Oveporexton in narcolepsy type 1. N Engl J Med. 2025. https://doi.org/10.1056/NEJMoa2405847 8. Harel BT, et al. Psychomotor vigilance test threshold in narcolepsy type 1. Ther Innov Regul Sci. 2026. https://doi.org/10.1007/s43441-026-01... 9. Sun Y, Gao J. Oveporexton: first-in-class orexin receptor 2 agonist. Drug Discov Ther. 2026. https://doi.org/10.5582/ddt.2026.01056 10. Schneider-Helmert D, et al. Effects of DSIP on human sleep behavior. Int J Clin Pharmacol Ther Toxicol. 1981. https://pubmed.ncbi.nlm.nih.gov/6895513/ 11. Monti JM, et al. DSIP efficacy in chronic insomniacs. Int J Clin Pharmacol Res. 1987. https://pubmed.ncbi.nlm.nih.gov/3583493/ 12. Bes F, et al. Effects of DSIP on sleep of chronic insomniac patients. Neuropsychobiology. 1992. https://doi.org/10.1159/000118919 13. Araj SK, et al. Overview of Epitalon. Int J Mol Sci. 2025. https://doi.org/10.3390/ijms26062691 14. Izawa S, et al. REM sleep-active MCH neurons and forgetting. Science. 2019. https://doi.org/10.1126/science.aax9238 15. Edinger JD, et al. Behavioral and psychological treatments for chronic insomnia: AASM guideline. J Clin Sleep Med. 2021. https://doi.org/10.5664/jcsm.8986 16. FDA Pharmacy Compounding Advisory Committee, July 23-24, 2026. Briefing materials for 7 bulk drug substances including DSIP (emideltide), Epitalon, and Semax. https://www.fda.gov/advisory-committe... 17. FDA approval of ORZEYFUL (oveporexton), August 5, 2026. https://www.drugs.com/history/orzeyfu... DISCLAIMER This video is for general education only. It is not medical advice and does not create a physician-patient relationship. I'm a physician, but I'm not your physician. Nothing here should be used to diagnose or treat any condition, or to start, stop, or change any medication or supplement. Talk to a licensed clinician who knows your history and your other prescriptions before making decisions about your health. The peptides discussed here are not FDA-approved treatments for insomnia. Products sold outside a regulated pharmaceutical supply chain carry risks of unknown identity, dose, purity, and sterility. If you're struggling with sleep, please see a clinician. Sudden or severe daytime sleepiness, especially while driving, is a medical and safety issue. #SleepPeptides #DSIP #Epitalon #Orexin #Insomnia